• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Innovation: Is it just lightning in a bottle?

Innovation: Is it just lightning in a bottle?

October 20, 2011 By MassDevice

By Naomi Fried

The word innovation gets thrown around a lot these days by people trying to set their products and ideas apart from everything else out there. But when everything is innovative, is anything really innovative? And if there really are innovative ideas out there, are they simply flashes of brilliance that can’t be planned for or predicted?

The answer to this last question is “no,” as I see every day as Chief Innovation Officer here at Children’s Hospital Boston. The real trick is creating an innovation culture that supports great ideas – but that also supports the not-so-great ideas that teach us almost as much.

So what are the attributes of an “innovation culture”?

First, people must feel safe – to experiment, to take risks and, most importantly, to fail. Failure is a critical ingredient of innovation; progress rarely can be made without it. To make people feel safe to fail, there must be no significant penalties for failure. In fact, we need to look at failure as an opportunity to learn what went wrong so we can do better the next time. And we have to encourage our innovators to share what didn’t work and what they learned, and then go back to the drawing board to try again.

I knew we were well on our way to creating a safe innovation environment when, at a recent meeting, one of our well-respected clinical department heads volunteered that his great idea had been an abject failure. No one berated him or mocked him, but instead listened for the lessons learned and moved on.

Second, an innovation culture is open. People are nonjudgmental and welcoming. All types of innovation are accepted. Just as it’s okay to fail, it is okay to have small-scale successes and improvements, not just the really big new ideas. Just as “the perfect can be the enemy of the good,” we need to make sure that our preoccupation with paradigm-shifting, disruptive innovation doesn’t cause us to denigrate the value of incremental, small-scale innovation. In fact, small changes can often add up to something big.

One great and recent example is work done by the parking and Commuter Services Office to streamline the return of valet-parked cars to our patients’ families leaving the Emergency Department. In five months, their hard work resulted in being able to return almost 90 percent of the cars in less than 15 minutes, a major improvement in throughput.

It’s much easier to catch lightning in a bottle when you’ve created the atmosphere for brainstorms.

Vector

Third, an innovation culture is one in which the innovator feels supported. That support can take many forms. For starters, people need the time to innovate – to notice problems, brainstorm new ideas and test their theories. It’s hard to create a culture conducive to innovation if people don’t have time to reflect and think. To foster innovation, Google allows their engineers to spend 20 percent of their time away from their assigned projects, experimenting with new ideas. Half of Google’s new innovations have come from ideas developed in this “20 percent time.”

To make an innovation a reality, people also need access to resources for testing and developing ideas – including seed money, software expertise, space and, most importantly, advice. Guidance and support (especially when things are failing!) go a long way in creating an innovation culture. Mentors and innovation experts who can share their lessons are a valuable institutional resource. And learning the ropes from experienced innovators is a great way for novice innovators to get started.

Just ask Karen Sakakeeny. Karen is a nurse who, after 33 years at Children’s, decided to try her hand at innovation with a hat for rewarming infants undergoing open-heart surgery. With an innovation grant and the support of a team of innovation and patient-care experts, Karen is now navigating the innovation process quite successfully.

We are extremely fortunate here at Children’s to have leaders who understand that building an innovation culture requires resources. They supported the formation of the Innovation Acceleration Program team and have provided time, money and space for innovation. We have a seed fund for clinical innovation, the Innovestment Grant program, the FIT software development team (which focuses on developing innovative new technology solutions), and many institutionally supported opportunities to share ideas and learn from each other.

But changing people’s attitude toward failure and creating a safe and open environment takes time, work and commitment across the organization. A year into our team’s work, we’re well on our way to becoming a hospital culture that supports innovation – and proving that it’s much easier to catch lightning in a bottle when you’ve created the atmosphere for brainstorms.

Naomi Fried, PhD, is Children’s Hospital Boston’s first Chief Innovation Officer. Her mission is to build and develop a program in clinical innovation, aimed at improving care quality and assisting the hospital in shaping the future of health care. Read more about her on our Bloggers page or the Innovation Acceleration Program website.

Filed Under: News Well, Research & Development Tagged With: Boston Children's Hospital

In case you missed it

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Dyad Medical wins FDA clearance for cardiac imaging platform Echo:Prio
  • Outset Medical wins national VA contract
  • Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year
  • Ambu is letting go of 200 employees
  • Medtronic has Class I recall for low-shock risk in ICDs
  • Titan Medical to start manufacturing Enos systems later this year
  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Cardinal Health’s CFO to move up to corner office
  • Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy

RSS From Medical Design & Outsourcing

  • TE Connectivity opens global medical device prototyping center in Ireland
    TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy